Spinal cord injury (SCI) triggers chronic intraspinal inflammation consisting of activated resident and infiltrating immune cells (especially microglia/macrophages). The environmental factors contributing to this protracted inflammation are not well understood; however, myelin lipid debris is a hallmark of SCI. Myelin is also a potent macrophage stimulus and target of complement-mediated clearance and inflammation. The downstream effects of these neuroimmune interactions have the potential to contribute to ongoing pathology or facilitate repair. This depends in large part on whether myelin drives pathological or reparative macrophage activation states, commonly referred to as M1 (proinflammatory) or M2 (alternatively) macrophages, respectively. Here we review the processes by which myelin debris may be cleared through macrophage surface receptors and the complement system, how this differentially influences macrophage and microglial activation states, and how the cellular functions of these myelin macrophages and complement proteins contribute to chronic inflammation and secondary injury after SCI. While numerous studies have examined how macrophage activation states affect recovery after SCI (for a review see Gensel & Zhang, 2015) , less is understood about how the lesion environment contributes to macrophage polarization. It is well established that myelin debris generated after SCI inhibits axonal regeneration and remyelination (McKerracher et al., 1994) ; however, myelin can also act as an inflammatory stimulus (Kroner et al., 2014; Williams, Ulvestad, Waage, Antel, & McLaurin, 1994) . Lipid-laden myelin debris is taken up and processed by inflammatory cells including neutrophils and macrophages. Myelin then becomes highly concentrated in these phagocytes, persisting in macrophages for weeks after SCI (Greenhalgh & David, 2014; Vargas & Barres, 2007; . In addition, 
| I N TR ODU C TI ON
Spinal cord injury (SCI) triggers a complex cross talk between resident cells of the central nervous system (CNS) and infiltrating immune cells.
These neuroimmune interactions can mediate recovery but also inhibit regeneration. Activated macrophages, consisting of resident microglia and recruited monocytes, contribute to this dichotomous response.
Indeed, macrophages facilitate repair by increasing axon growth, stem cell differentiation, and revascularization. However, macrophages can also contribute to pathology through reactive oxygen species (ROS), neurotoxin, and proinflammatory cytokine release, as well as by causing axon retraction and dieback. The extent to which macrophages are polarized toward reparative (also called M2 or alternative) or pathological (also called M1 or proinflammatory) phenotypes depends in large part on the stimuli present in the injured spinal cord.
While numerous studies have examined how macrophage activation states affect recovery after SCI (for a review see Gensel & Zhang, 2015) , less is understood about how the lesion environment contributes to macrophage polarization. It is well established that myelin debris generated after SCI inhibits axonal regeneration and remyelination (McKerracher et al., 1994) ; however, myelin can also act as an inflammatory stimulus (Kroner et al., 2014; Williams, Ulvestad, Waage, Antel, & McLaurin, 1994) . Lipid-laden myelin debris is taken up and processed by inflammatory cells including neutrophils and macrophages. Myelin then becomes highly concentrated in these phagocytes, persisting in macrophages for weeks after SCI (Greenhalgh & David, 2014; Vargas & Barres, 2007; . In addition, myelin initiates complement-mediated inflammatory pathways with downstream effects on macrophage activation. This review focuses on the myelin-macrophage and complement neuroimmune interactions
Significance
Myelin debris and chronic inflammation are hallmarks of central nervous system pathology. Understanding the neuroimmune interactions between myelin and inflammatory mediators such as macrophages and complement has the potential to uncover novel therapeutic targets applicable for a range of central nervous system disorders. after SCI. Since myelin is ubiquitously present in the acute and chronically injured spinal cord, we will explore the mechanisms of myelin debris clearance and its downstream inflammatory effects.
| SC I CA U SES M YE LI N BR EA KD OWN A N D I M M U N E C EL L A C TI VA TI ON
Acute spinal cord trauma ruptures vasculature, leading to tissue ischemia and blood-brain barrier breakdown and generating neuron and myelin debris. Myelin damage specifically occurs at the time of injury, and cellular debris is present in areas of white matter damage within 24 hr (Buss et al., 2005; Ek et al., 2012; Imai et al., 2008) . Debris increases within the first week of SCI and persists in the chronically injured spinal cord (Ek et al., 2012; Kozlowski, Rosicka, Liu, Yung, & Tetzlaff, 2014) . While damaged myelin is cleared within weeks of peripheral nerve injury, myelin fragments are present for the first year after SCI (Becerra et al., 1995; Vargas & Barres, 2007) . Indeed, myelin debris is not cleared from the chronically injured spinal cord until years after injury (Becerra et al., 1995) . This time course of acute myelin debris with protracted but eventual removal after SCI occurs across a range of mammalian models and in humans . The sustained presence of myelin debris inhibits axon regeneration, oligodendrocyte differentiation, and remyelination.
Immune cell activation follows a similar time course (Gensel & Zhang, 2015) . Neutrophils and complement proteins (discussed below) enter the injury site within the first days after SCI. Microglia are activated at the time of injury with peak activation within the first week of injury.
Monocyte-derived macrophages infiltrate the injured spinal cord within days and peak at 1 to 2 weeks after injury. Over time, neutrophils and complement proteins subside, but microglia and macrophages persist.
Phagocytosis markers are present on these chronically activated cells (Fleming et al., 2006) . It is therefore likely that myelin lipids are actively processed by macrophages and are environmental stimuli influencing chronic spinal cord inflammation. Indeed, in areas of Wallerian degeneration, macrophages disappear from the chronically injured spinal cord concomitant with myelin debris clearance (Becerra et al., 1995) .
| M A CR OP H AG E R EC EP TOR -M ED I AT ED M Y EL I N R E M OVA L
Receptor-mediated phagocytic myelin removal requires binding of damaged myelin to surface receptors and subsequent phagocytosis. These receptors have the potential to bind to myelin directly or to opsonized myelin particles. Both opsonized and nonopsonized myelin removal by macrophages/microglia have been reviewed extensively and will only be mentioned here briefly (Hirata & Kawabuchi, 2002; Neumann, Kotter, & Franklin, 2009; Rotshenker, 2003) . Complement-mediated receptor binding, primarily through the pattern recognition receptor (PRR), complement receptor 3 (CR3/CD11b/MAC-1), is a commonly studied mechanism of opsonized myelin clearance. Complement proteins (e.g., complement protein 3) and/or antibodies bind degenerated myelin facilitating CR3 binding and phagocytosis. This process, and the process of nonopsonized myelin clearance, is regulated in part through carbohydrate-lectin receptors including the MAC-2/Galectin-3 receptor among others. The receptormediated internalization of myelin, and myelin-receptor binding itself, potentially alters the functional phenotype of the phagocyte. The downstream effects of complement and receptor-mediated myelin removal on macrophage/microglia phenotypes will be discussed below.
It is also well documented that scavenger receptor AI/II (SRAI/II) participates in macrophage-mediated myelin clearance (for a review see Rotshenker, 2009 ). This PRR is capable of binding a variety of lipids and polyanionic ligands. SRAI/II, in combination with CR3, facilitates myelin phagocytosis by microglia and macrophages (da Costa, van der Laan, Dijkstra, & Br€ uck, 1997; Reichert & Rotshenker, 2003) . Additionally, SRAI/II is implicated as a primary mediator of oxidized lipoprotein uptake in atherosclerosis and leads to the development of foam cells (Greaves & Gordon, 2009 ). Emerging transcriptional evidence indicates that SCI macrophages increase lipid catabolism after injury and adopt transcription profiles closely resembling foam cells (Zhu et al., 2017) . Lipoprotein receptors have been implicated in the foam cell transition, but whether SRAI/II facilitates this transition in SCI has yet to be determined. This may be challenging considering that SCI results in significant free radical generation and lipid peroxidation (Hall, 2011) . It is possible that these oxidative alterations to myelin lipids may alter the receptor pathways through which they are cleared, and this caveat is important to consider when modeling myelin clearance in vitro and interpreting experimental results.
Another potential mechanism of receptor-mediated myelin clearance is through the macrophage receptor with a collagenous structure (MARCO). MARCO is a scavenger receptor related to SRAI/II. Both contain collagenous and scavenger receptor cysteine-rich domains in their extracellular portions, giving them similar ligand-binding repertoires (Elomaa et al., 1995; J ozefowski, Arredouani, Sulahian, & Kobzik, 2005) . Thus, it is likely that MARCO can bind myelin lipids effectively.
Although it has not been identified as a myelin receptor in SCI, we recently observed that macrophages upregulate MARCO in response to proinflammatory stimuli and express MARCO in the injured spinal cord (Gensel, Kopper, Zhang, Orr, & Bailey, 2017; Orr et al., 2017) .
MARCO activation, therefore, may be a potential mechanism for proinflammatory macrophage-mediated myelin removal in SCI.
Triggering receptor expressed on myeloid cells 2 (TREM2) facilitates microglial phagocytic activity (Takahashi, Rochford, & Neumann, 2005) . TREM2 is a sensor for lipid components of damaged myelin and is required for debris clearance in the cuprizone model of demyelination (Daws et al., 2003; Poliani et al., 2015) . TREM2 binds polyanionic ligands, such as dextran sulfate, bacterial lipooligosaccharides, and various phospholipids (Cannon, O'Driscoll, & Litman, 2012) . In the case of myelin the likely ligands include phosphatidylethanolamine, phosphatidylserine, and cardiolipin found in myelin membranes (Cannon et al., 2012) . Individuals with TREM2 mutations or deficiencies are at higher risk for developing amyotrophic lateral sclerosis, Parkinson disease, and Alzheimer disease (Lill et al., 2015) . Notably, individuals with mutations in TREM2 or DAP12, a key signaling component of TREM2, develop lethal and progressive Nasu-Hakola disease characterized by early-onset dementia and demyelinating brain lesions (Paloneva, Autti, Hakola, & Haltia, 2002; Verloes et al., 1997) . Therefore, TREM2 may be involved in removing damaged myelin following SCI, multiple sclerosis (MS), and other conditions. Indeed, microglial TREM2 senses lipid components of myelin debris and is important in regulating transcriptional programs essential for myelin debris clearance (Cantoni et al., 2015; Poliani et al., 2015; Siddiqui, Lively, & Schlichter, 2016) . Additional work is needed to examine TREM2 within the context of the myelin-macrophage interactions in SCI. Likewise, TREM2 is part of a large family of TREM and TREM-like receptors with similar ligandbinding repertoires that are also unstudied in the context of myelin uptake after SCI (Cannon et al., 2012) .
| M Y EL I N-M A CROP H A GE I NT ER A CTI ON S
Some of the first studies to examine macrophage-mediated myelin debris clearance in the CNS emerged from the MS field. Electron microcopy studies revealed myelin debris phagocytosis in active lesions and identified macrophages as facilitators of continued demyelination (Prineas, 1975; Prineas & Connell, 1978) . This catalyzed further studies largely concerned with the roles of anti-myelin antibodies, complement, and other pathways in relation to the chronic demyelination observed in MS. A 1994 publication by Williams et al. in the Journal of Neuroscience Research identified an inflammatory role for myelin debris (Williams et al., 1994) . Specifically, they reported microglial activation with increased proinflammatory cytokine and ROS production with myelin phagocytosis (Williams et al., 1994) . These observations indicate that myelin debris may be an inflammatory stimulus for proinflammatory microglia/macrophage activation.
In the 1990s, work by Br€ uck and Friede and van der Laan et al. demonstrated the importance of macrophage CR3 in mediating myelin uptake. They observed that myelin induced production of tumor necrosis factor-alpha (TNF-a) and nitric oxide (van der Laan et al., 1996) . These effects were enhanced through complement opsonization of myelin and blocked through antibody-mediated-inhibition of CR3 (Br€ uck & Friede, 1990 , 1991 van der Laan et al., 1996) . This work is supported by a more recent study in an SCI model which reported myelin invoked proinflammatory macrophage responses in vivo (Sun et al., 2010) . In that paper, CR3-mediated uptake of myelin and downstream activation of FAK/ PI3K/Akt/NF-jb signaling pathways increased proinflammatory, M1-like cytokine release and decreased M2 cytokine release (Sun et al., 2010) . Collectively, these data highlight that receptor-mediated myelin removal can alter macrophage phenotypes and that removal through CR3 drives proinflammatory macrophage activation in SCI.
While these studies implicate myelin as a proinflammatory macrophage stimulus in SCI, the role of myelin and lipid processing on M1/M2 macrophage polarization in vivo is controversial. Specifically, myelinladen "foamy" cells express a wide variety of anti-inflammatory molecules with some intermediate M1-M2 phenotypes in MS (Boven et al., 2006; Vogel et al., 2013) . In arthrosclerosis, foam cell formation is associated with downregulation of proinflammatory gene expression (Spann et al., 2012) . In contrast, in SCI, foam cell formation and macrophage lipid accumulation are associated with decreased M2 activation . Further, M1 macrophage polarization predominates in SCI despite the large presence of myelin debris (Kroner et al., 2014) . Interestingly, the relative expression of pro-and anti-inflammatory markers appears to depend on the lesion or tissue microenvironment. For example, in active MS lesions, anti-inflammatory marker expression predominates on foam cell macrophages in the lesion center and inner rim, while proinflammatory marker expression is more widespread (Boven et al., 2006; Vogel et al., 2013) . Similarly, a more recent evaluation of foam cells within the context of the M1/M2 macrophage paradigm observed a full range of M1-M2 foam cell activation states depending on the microenvironments from which the cells were isolated (Thomas, Eijgelaar, Daemen, & Newby, 2015a; 2015b) . In the case of SCI, two environmental cues that may promote M1 polarization in the presence of myelin are TNF and intracellular iron, perhaps reflective of the increased hemorrhage in SCI lesions relative to those in MS (Kroner et al., 2014) .
To better elucidate the role myelin plays in macrophage polarization, researchers often stimulate macrophages with myelin in vitro.
However, despite using fairly similar stimulation paradigms, there are contrasting reports that implicate myelin as both a proinflammatory and anti-inflammatory stimulus. To better understand how to reconcile these conflicting reports, we examined the myelin stimulations in detail.
A few common themes emerged that may account for the conflicting results. First, in several of these in vitro paradigms, researchers load macrophages with myelin prior to applying inflammatory stimuli. In response to proinflammatory stimuli, these myelin-laden macrophages almost invariably express anti-inflammatory mediators and/or stop responding to the proinflammatory stimuli (Bogie et al., 2012 (Bogie et al., , 2013 Boven et al., 2006) . Second, myelin stimulation in isolation invokes either no phenotypic activation or causes release of ROS and proinflammatory cytokines, with a few reports of subtle M2-like activation in a cell type-specific manner (Kroner et al., 2014; Sun et al., 2010; van der Laan et al., 1996; van Rossum, Hilbert, Straßenburg, Hanisch, & Br€ uck, 2008; Williams et al., 1994) . Third, when myelin is delivered to macrophages already stimulated to be either M1 or M2, or when myelin and other stimuli are presented at the same time, a range of responses has been reported. For example, prestimulation with M1 or M2 stimuli results in a myelin-induced potentiation of M1 activation (Siddiqui et al., 2016; . Myelin coadministration with proinflammatory stimuli can invoke further M1 activation, albeit in a time-dependent manner with increased M2 activation over time (Liu et al., 2006) . A subtly distinct protocol added myelin to M1 polarized macrophages following the removal of the inflammatory stimuli and observed anti-inflammatory effects (Kroner et al., 2014) .
Notably, in that study, if proinflammatory stimuli are present during myelin activation, M1 polarization was observed (Kroner et al., 2014) .
It is also important to note that researchers use various cell types including bone marrow-derived macrophages, primary microglia, cell lines, peritoneal macrophages, and blood monocytes among others for in vitro models. All of these cell types have subtle differences in their basal activation state and their ability to take up and respond to myelin In addition, the macrophage response to myelin uptake varies depending on the receptors mediating phagocytosis (Figure 1) . In traditional responses to infection and damage, macrophage PRRs often share redundancies in the molecular structures they target. It has been proposed that collective engagement of different PRRs can influence the cellular response to an inflammatory insult (J ozefowski et al., 2005; Mukhopadhyay, Herre, Brown, & Gordon, 2004) . Indeed, in SCI, the collaborative engagement of PRRs, versus activation in isolation, yields distinct reparative or pathological functions . Notably, the PRRs capable of recognizing and clearing myelin, as discussed above, appear to mediate contrasting cellular responses along the spectrum of macrophage activation states. This suggests that the specific combination of myelin clearance receptors used after injury may influence the inflammatory effects of myelin debris. For example, in vitro, MARCO is important in mediating proinflammatory IL-12 production in response to inflammatory stimuli (J ozefowski et al., 2005) . Similarly, it is well documented that macrophages increase IL-12 release with myelin stimulation (Sun et al., 2010; . Given that MARCO is present on macrophages after SCI Additionally, TREM2 plays a role in myelin clearance and integrity.
As discussed above, it is important in regulating the transcriptional programs essential for myelin phagocytosis (Cantoni et al., 2015; Poliani et al., 2015; Siddiqui et al., 2016) . Further, TREM2 signaling facilitates the production of trophic factors important in oligodendrocyte differentiation, survival, and remyelination (Poliani et al., 2015) . Interestingly, overexpression of TREM2 increases the efficiency of noninflammatory phagocytosis (Takahashi et al., 2005; Takahashi, Prinz, Stagi, Chechneva, & Neumann, 2007) . TREM2 overexpression in macrophages also induces an M2 phenotype, and M2 activation is inhibited in TREM2 KO macrophages (Seno et al., 2009; Takahashi et al., 2005) . In an experimental model of MS, TREM2 facilitated myelin removal while increasing anti-inflammatory cytokine production (Takahashi et al., 2007) . Whether TREM2 drives M2 macrophage activation in the context of SCI is unknown, but these studies suggest that it may be a proreparative pathway for myelin debris clearance. CD36 (a class B scavenger receptor) is also implicated in macrophage-mediated myelin clearance after SCI. Recently, Zhu et al. (2017) examined shifts in macrophage transcriptional profiles from 3 to 7 days post injury (dpi). They observed a significant shift from genes controlling cytokine signaling and cellular migration at 3 dpi to a profile dominated by lipid catabolism at 7 dpi through the liver X receptor and retinoid X receptor (RXR) and peroxisome proliferator-activated receptor/RXR canonical pathways (Zhu et al., 2017) . Further, they targeted the most enriched lipid receptor identified, CD36, and found that its genetic deletion reduced lipid accumulation in macrophages and improved functional outcomes after SCI (Zhu et al., 2017) . Interestingly, signaling . Further, while myelin increased lipid efflux and activated ATP-binding cassette transporter A1 in macrophages, in foamy cells, myelin decreased the phagocytic capacity for necrotic neutrophils . Since foamy macrophages are present in SCI, they proposed that these spent, but nonphagocytosed, neutrophils released toxins and contribute to secondary injury after SCI. This is a novel potential mechanism through which foam-like, myelin-laden macrophages may contribute to secondary injury processes . Given the extensive lipid debris accumulating within SCI macrophages, additional comparisons to foam cells and atherosclerosis may lead to new therapeutic targets.
Another important factor that likely regulates the myelin-macrophage neuroimmune interaction in SCI is phagocytic cell origin. Microglia have the phagocytic capacity to remove damaged myelin and are the predominant phagocyte to clear debris in the acutely injured spinal cord (Greenhalgh & David, 2014) . However, by 3 days post injury, this role is largely taken over by infiltrating macrophages (Greenhalgh & David, 2014) . Specifically, in the first weeks after SCI, MAC-2 1 bone marrow-derived macrophages enter the lesion site and are positive for myelin debris . These infiltrating macrophages accumulate in the lesion over time and contain lipid debris for at least 42 dpi (Greenhalgh & David, 2014) . In contrast, CX3CR1 high resident microglia are primarily found along the periphery of the lesion/lipid plaque in areas of less concentrated myelin debris .
The downstream effects of this differential distribution of macrophages and microglia relative to lipid debris have been discussed previously (Zhou, He, & Ren, 2014) , but it is interesting to consider how cellspecific receptor expression may mediate myelin polarization in SCI.
For example, MARCO is primarily expressed by infiltrating and not resident myeloid cells (Getts et al., 2014) . Similarly, MAC-2 expression is specific to monocyte-derived macrophages after SCI . TREM2, however, is predominantly expressed by microglia (Schmid et al., 2002) . As discussed above, these receptors have different propensities for proinflammatory or anti-inflammatory cytokine release in response to myelin stimulation (Figure 1 ). It is therefore possible that varied receptor expression on microglia and monocytederived macrophages predisposes these cells for different inflammatory responses to SCI myelin debris. Determining the relative contribution of microglia versus macrophages on myelin-mediated SCI inflammation will be challenging, however, based on the observation that macrophage myelin phagocytosis varies depending on the inflammatory cues driving recruitment to the site of injury (Slobodov, Reichert, Mirski, & Rotshenker, 2001 ).
Relative to the injured spinal cord, myelin may induce deleterious proinflammatory macrophage activation (Kroner et al., 2014; . Myelin and myelin phagocytosis likely potentiate signaling pathways and polarization states in macrophages and function as direct inflammatory stimuli (Figure 1 ). Determining the mechanisms and environmental conditions through which myelin can induce these effects in immune cells could lead to novel therapies for SCI and other neuroinflammatory disorders.
| C OM PL EM E N T-M ED I AT ED M YE LI N C LE AR A NC E
In addition to macrophages, the complement system is a key inflamma- responses to SCI in addition to its other direct functions (Peterson & Anderson, 2014; Sun et al., 2010; van der Laan et al., 1996) . Further, the activation of this immune pathway through myelin interactions, DAMPs, or other means can directly damage intact myelin, oligodendrocytes, and neurons, thereby driving inflammation by increasing myelin and cellular debris or other inflammatory mediators.
The primary source of complement is the liver. It produces substantial quantities of inactive complement. This complement is stored in the plasma until it is activated in response to infection or damage.
After SCI, disruption of the blood-brain barrier allows complement proteins to enter the lesion site. Indeed, complement increases in the injured spinal cord within 1 day of SCI in both rats and humans . SCI-induced inflammatory cytokines may also increase complement serum levels at these acute time points (Rebhun & Botvin, 1980) . While plasma-derived complement is likely the main initiator of early myelin clearance after SCI, complement is present in the chronically injured spinal cord (Anderson, Robert, Huang, Young, & Cotman, 2004) to oligodendrocyte myelin glycoprotein (OMgp) drives myelin opsonization and clearance (Johns & Bernard, 1997) . OMgp contains an amino acid motif that shares homology with C1q-binding sites on PAMPs/DAMPs (Johns & Bernard, 1997) . OMgp and C1q levels increase after SCI (Anderson et al., 2004; Dou et al., 2009) . Since C1q binding to OMgp initiates complement activation, it is likely that C1q mediates myelin debris clearance and inflammation after SCI (Figure 2 ).
Indeed, C1q knockout mice have improved SCI recovery and tissue sparing and altered macrophage activation compared with wild-type SCI controls .
Another potentially important complement protein in myelinimmune interactions after SCI is C5. Studies conducted primarily in models of MS and Alzheimer disease demonstrate that formation of the C5b-9 membrane attack complex on oligodendrocytes leads to extensive demyelination and oligodendrocyte cell death (Bradt, Kolb, & Cooper, 1998; Liu, Vanguri, & Shin, 1983; Rus, Cudrici, David, & Niculescu, 2006) . This lytic attack requires the proteolytic cleavage of complement into bioactive proteins including C5a, among others ( Figure 2 ).
While not well understood within the CNS, in the periphery C5a binds to receptors on mast cells and basophils, ultimately inducing degranulation and release of vasoactive substances. These substances, such as histamine, increase blood vessel permeability (Parham, 2009) . Further, C5a is a potent chemoattractant for monocytes and neutrophils (Marder, Chenoweth, Goldstein, & Perez, 1985) . C5a can therefore drive inflammation by increasing recruitment and efflux of immune cells from the blood to sites of cellular debris (Miller & Stella, 2009 ). In the context of myelin debris-induced complement activation after SCI, increased C5a could act as an ongoing recruitment signal and mediator of macrophage entry into the injury site. A recent study demonstrated that loss of C5aR, the receptor for C5a, reduces macrophage recruitment and inflammatory cytokine production early after SCI (Brennan et al., 2015) . Further, C5a has direct apoptotic effects on neurons that may contribute to secondary injury, thereby increasing cellular debris (Farkas, Baranyi, Liposits, Yamamoto, & Okada, 1998; Humayun et al., 2009) The C5 convertase initiates the cleavage of C5 and the subsequent recruitment of C6-9, creating the C5b-9 membrane attack complex capable of rupturing myelin membrane debris or intact oligodendrocytes. (F) The C5a fragment released during this process acts as both a potent recruitment signal for macrophages to the site of complement opsonization, through the C5 receptor (C5aR), and as a proinflammatory, vasoactive stimulus on a variety of other cell types. References can be found in the main text dependent. Targeting these pathways and receptors opens the possibility for therapeutic interventions to improve recovery after SCI. Further, given myelin's ubiquitous presence in the CNS, the development of new therapies will likely impact a variety of disorders in which complement, myelin, and macrophage interactions contribute to persistent inflammation.
